Skip to main navigation menu Skip to main content Skip to site footer

Miliary tuberculosis with hematogenous spread after intravesical BCG instillations: A case report

Tuberculosis miliar con diseminación hematógena posterior a instilaciones de BCG intravesical: reporte de un caso




Section
Reporte de caso

How to Cite
Dajaro-Castro LA, McBrown-Ferro MV, Lasso-Apraez J. Miliary tuberculosis with hematogenous spread after intravesical BCG instillations: A case report.
rev. colomb. neumol. [Internet]. 2025 Jan. 20 [cited 2025 May 30];37(1):63-8. Disponible en: https://doi.org/10.30789/rcneumologia.v.n. 731

Dimensions
PlumX
license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.


Leonel Alberto Dajaro-Castro,

Médico internista- Fellow de neumología, Servicio de Neumología, Hospital Universitario San Ignacio, Pontifica Universidad Javeriana


María Victoria McBrown-Ferro,

Médico internista- Fellow de neumología, Servicio de Neumología, Hospital Universitario San Ignacio, Pontifica Universidad Javeriana


Javier Lasso-Apraez,

Neumólogo – Médico internista – Profesor asociado, Servicio de Neumología 


Miliary tuberculosis after intravesical immunotherapy with bacillus Calmette-Guerin (BCG) is rare. A few systemic complications associated with intravesical BCG instillations have been reported in the literature. In this case report, we present a patient with low-grade urothelial bladder cancer who presented clinical manifestations compatible with tuberculosis 4 hours after the last instillation of BCG as immunotherapy treatment for his bladder cancer. Consequently, a systematic approach was performed, finding micronodular infiltrates of random distribution in thoracic images suggestive of a Miliary pattern. 

The patient started anti-tuberculous treatment at the decision of an interdisciplinary board. Among the tests carried out, it was found that the endoscopic flexible fiberoptic bronchoscopy did not present alterations, the stains for AFB (acid-fast bacilli) in bronchoalveolar lavage were negative, as was the Gnexpert for Tuberculosis and culture. However, due to the symptoms and relevant risk factors, it was decided to perform wedge resection by thoracoscopy of the middle lobe, revealing a necrotizing granulomatous process whose histological appearance favored infectious etiology. The patient was diagnosed with miliary tuberculosis because of the symptoms presented, compatible radiology, biopsy findings, and clinical improvement, considering the antituberculosis treatment established.

This article describes a case of miliary tuberculosis hematogenous spread in a patient who had previously received intravesical BCG instillations for the treatment of urothelial bladder cancer. Prompt treatment saves lives by avoiding a fatal outcome in these patients.


Article visits 100 | PDF visits 33


Downloads

Download data is not yet available.
  1. Chou , Selph , Buckley DI, Fu , Griffin JC, Grusing , et al. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. The Journal of Urology. 2017 May; 197(5). doi: 10.1016/j.juro.2016.12.090 DOI: https://doi.org/10.1016/j.juro.2016.12.090
  2. Sfakianos M.D. JP, Berengere. Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer. Urologic Oncology: Seminars and Original Investigations. 2021 Feb; 39 (121-129). DOI: 10.1016/j.urolonc.2020.09.031 DOI: https://doi.org/10.1016/j.urolonc.2020.09.031
  3. Lobna L, Nesrine , Kaddoussi , Mabrouk , Saoussen Cheikh M, Naceur R. Miliary tuberculosis following intravesical Bacillus Calmette and Guérin therapy: A rare complication of a frequent procedure. Elsevier, Urology Case Reports. 2021; 38(101655) PMCID: PMC8040259 PMID: 33868941 DOI: https://doi.org/10.1016/j.eucr.2021.101655
  4. Steg A, Leleu C, Debré , Boccon-Gibod , Sica. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. Prog Clin Biol Res. 1989. PMID: 2672020 DOI: https://doi.org/10.1159/000471561
  5. Guallar-Garrido , Julián. Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update. ImmunoTargets and Therapy. 2020. PMCID: PMC7025668 PMID: 32104666 DOI: https://doi.org/10.2147/ITT.S202006
Sistema OJS 3.4.0.7 - Metabiblioteca |